Not provided
Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| DRKS00022175 | Registry Identifier | German clinical trials register |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| University of Education Freiburg | UNKNOWN |
| Deutsche Gesellschaft für Thorax-, Herz- und Gefäßchirurgie (DGTHG) | UNKNOWN |
| Stiftung Institut fuer Herzinfarktforschung | OTHER |
Not provided
Not provided
Not provided
Not provided
Myocardial infarction and chronic coronary heart disease (cCHD) are the most frequent causes of death in Germany. Treatment options include widening of the narrowed / blocked coronary vessel via catheter and stent or bypass surgery in which the narrowed vessel sites are bridged. The "German National Disease Management Guideline on cCHD" helps doctors to decide which treatment is most appropriate for the severity of vascular damage and possible concomitant diseases of the patient. Nevertheless, there are other factors determining treatment decision. For example, the equipment or preferences of the hospital or department in which patients are admitted, play a role in the decision.
The aim of the REVASK project is to investigate whether and to what extent the collaboration of cardiology and heart surgery specialists in so-called "heart teams" influences the decision on therapy.
For this purpose, doctors and patients will be interviewed about how the treatment decision was made and how satisfied both sides are with the outcome of the treatment and the decision. In addition, claims data from several German health insurance companies (Techniker, BARMER, Betriebs- und Innungskrankenkassen) will be analyzed. Treatment data, which is documented as usual by the treating medical staff and passed on to the health insurance companies for accounting purposes, is used. Furthermore, treatment data recorded in the registers of the professional societies is analyzed.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patients with CHD | outpatient cardiology practices, hospitals with a cardiology department and hospitals with a cardiology and heart surgery department (n=20) in Germany Patients with chronic coronary heart disease and 2- or 3-vessel or main-vessel disease who are being treated at one of the recruitment sites with a promptly planned intervention for myocardial revascularization who are insured with pre-specified German health insurance companies (BARMER or TK) Patients will receive questionnaires. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Guideline compliance | Guidelines-compliant therapy in patients with chronic CHD (2- or 3-vessel or main vessel disease) according to German National Disease Management Guideline on chronic coronary heart disease | 2 years |
| Measure | Description | Time Frame |
|---|---|---|
| Heart teams | Frequency and quality of heart teams | 2 years |
| Patient participation | extent of patient participation in the decision making process |
Not provided
Inclusion Criteria:
Exclusion Criteria:
-
Not provided
Not provided
outpatient cardiology practices, hospitals with a cardiology department and hospitals with a cardiology and heart surgery department (n=20) in Germany
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jochen Walker, Dr. med. | InGef - Institute for Applied Health Research Berlin GmbH; Spittelmarkt 12, 10117 Berlin | Study Chair |
| Andreas Beckmann, Dr. med. | Deutsche Gesellschaft für Thorax-, Herz- und Gefäßchirurgie (DGTHG) | Principal Investigator |
| Uwe Zeymer, Prof. Dr. med. | Stiftung Institut für Herzinfarktforschung (IHF) | Principal Investigator |
| Peter Ihle | PMV forschungsgruppe, Universitätsklinikum Köln | Principal Investigator |
| Ursula Marschall, Dr.med. | BARMER | Principal Investigator |
| Ines Meier, Dr. | Techniker Krankenkasse | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Pädagogische Hochschule Freiburg Public Health & Health Education | Freiburg im Breisgau | Germany |
Not provided
| Label | URL |
|---|---|
| The official website of the REVASK project | View source |
Not provided
Research data can be shared with persons or institutions with a legitimate scientific interest after consultation in the consortium and only in pseudonymised form and within the scope of the EU-GDPR
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003327 | Coronary Disease |
| ID | Term |
|---|---|
| D017202 | Myocardial Ischemia |
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D014652 | Vascular Diseases |
Not provided
Not provided
| Universitätsklinikum Köln |
| OTHER |
| BARMER | OTHER |
| Techniker Krankenkasse | OTHER |
Not provided
Not provided
Not provided
| 2 years |
| Decision making process | importance of clinical parameters in the decision-making process (e.g. syntax scores, iFR, FFR) | 2 years |